Feature

COVID-19: Dramatic changes to telepsychiatry rules and regs


 

In the wake of the coronavirus pandemic, the rules and regulations governing telepsychiatry services have changed dramatically, the most radical of which is the introduction of a new waiver by the Centers for Medicare & Medicaid Services.

Dr. Peter Yellowlees, a psychiatrist and chief wellness officer at the University of California, Davis Health

Dr. Peter Yellowlees

Under the 1135 emergency waiver, Medicare has expanded telehealth services to include patients across the country – not just in rural areas or under other limited conditions, as was previously the case. In addition, there’s now a waiver to the Ryan Haight Act that allows the prescribing of controlled substances via telemedicine.

Peter Yellowlees, MD, from University of California, Davis, reported that outpatient service at his center was converted to an almost 100% telepsychiatry service from mid- to late March.

He and John Torous, MD, director of digital psychiatry at Beth Israel Deaconess Medical Center, Boston, led a free webinar late last month sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA).

During the hour-long event, they answered questions and offered tips on changes in licensure, patient safety, new prescribing rules, and equipment needed.

“Clinicians need to be aware of these changes so they can ensure they are reaching as many people as possible and taking advantage of the reduced barriers to offering safe and effective video visits,” Dr. Torous said in an interview.

‘This is huge’

The new 1135 waiver “basically says CMS will pay for any patient on Medicare who is seen by video by any provider who is correctly licensed in any state in this country,” Dr. Yellowlees told webinar attendees.

“You don’t need to be licensed in the state where the patient is if the patient is on Medicare. This opens up a huge number of patients we can now see on video,” he said. “And you can bill at normal Medicare rates for whatever you normally get for your in-person patients.”

Although this temporary rule only applies to Medicare and not to private insurers, or to patients on Medicaid, “these are really big changes. This is huge,” Dr. Torous said.

Previously, the “originating site” rule stated that, for the most part, clinicians had to be licensed in the state where the patient was located and not where the physician was stationed.

Asked about college students receiving mental health care who were in school in the psychiatrist’s area but are now back home in a state where the clinician doesn’t have a license, Dr. Yellowlees said that scenario could be a bit “tricky.”

“Most of those patients probably aren’t on Medicare. Legally, you [usually] can’t see them on video if they have private insurance or Medicaid. So, hopefully you can give them a 3-month supply of medication and then recommend they see a local provider,” he said.

Still, all states have their own rules, Dr. Yellowlees said. He and Dr. Torous noted that the Federation of State Medical Boards has a “very up-to-date” listing of policies at FSMB.org, all of which are organized by state. In addition, the American Psychiatric Association provides a telepsychiatry toolkit on its website.

Pages

Recommended Reading

Are psychiatrists more prepared for COVID-19 than we think?
MDedge Dermatology
U.S. lifts visa halt to boost COVID-19 physician workforce
MDedge Dermatology
Firings, furloughs, and pay cuts in advance of COVID-19 surge
MDedge Dermatology
States allow doctors to practice across state lines during COVID-19 crisis
MDedge Dermatology
Close your practice temporarily ... or longer? Your decision during COVID-19
MDedge Dermatology
Maintaining cancer care in the face of COVID-19
MDedge Dermatology
NYU med student joins COVID fight: ‘Time to step up’
MDedge Dermatology
A decade of telemedicine policy has advanced in just 2 weeks
MDedge Dermatology
Which of the changes that coronavirus has forced upon us will remain?
MDedge Dermatology
AAP issues guidance on managing infants born to mothers with COVID-19
MDedge Dermatology